Compare EVO & VRTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | EVO | VRTS |
|---|---|---|
| Founded | 1993 | 1988 |
| Country | Germany | United States |
| Employees | 4553 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 934.1M | 968.0M |
| IPO Year | N/A | 1995 |
| Metric | EVO | VRTS |
|---|---|---|
| Price | $2.68 | $138.28 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 1 | 4 |
| Target Price | $7.00 | ★ $158.00 |
| AVG Volume (30 Days) | ★ 94.1K | 70.9K |
| Earning Date | 04-08-2026 | 05-01-2026 |
| Dividend Yield | N/A | ★ 6.68% |
| EPS Growth | N/A | ★ 18.24 |
| EPS | N/A | ★ 1.05 |
| Revenue | N/A | N/A |
| Revenue This Year | $1.37 | N/A |
| Revenue Next Year | $10.05 | $1.66 |
| P/E Ratio | ★ N/A | $135.77 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.31 | $121.61 |
| 52 Week High | $4.80 | $214.88 |
| Indicator | EVO | VRTS |
|---|---|---|
| Relative Strength Index (RSI) | 36.25 | 47.21 |
| Support Level | $2.32 | $135.82 |
| Resistance Level | $3.78 | $147.15 |
| Average True Range (ATR) | 0.09 | 5.82 |
| MACD | -0.06 | -0.50 |
| Stochastic Oscillator | 6.44 | 55.94 |
Evotec is a drug discovery partnership firm providing solutions to pharmaceutical and biotechnology companies, academic institutions, foundations, and nonprofit organizations. The company offers services in a variety of therapeutic areas, including central nervous system disorders, diabetes, inflammation, oncology, infectious diseases, and women's health. The shared R&D segment, roughly 80% of sales, provides drug discovery and manufacturing services on a typical fee-for-service basis and integrated drug discovery collaborations based on its proprietary, internally developed assets. The Just-Evotec Biologics segment, about 20% of sales, offers CDMO services for biologics. As of 2023, the company has over 5,000 employees and 18 production sites mainly in Europe and the United States.
Virtus Investment Partners Inc provides investment management and related services to institutions and individuals. It uses a multi-manager, multi-style approach, offering investment strategies from investment managers, each having its distinct investment style, autonomous investment process, and individual brand, as well as from select unaffiliated managers for certain funds. Through its multi-manager model, the group provides investment managers with distribution, business, and operational support. The Company operates in one business segment, namely as an asset manager providing investment management and related services for individual and institutional clients.